Preanalytical influences on DPC IMMULITE 2000 intact PTH assays of plasma and serum from dialysis patients.

1. Mair J, Hammerer-Lercher A, Puschendorf B. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure [Review]. Clin Chem Lab Med 2001;39:571–88. 2. Mir TS, Laux R, Hellwege HH, Liedke B, Heinze C, von Buelow H, et al. Plasma concentrations of aminoterminal pro atrial natriuretic peptide and aminoterminal pro brain natriuretic peptide in healthy neonates: marked and rapid increase after birth. Pediatrics 2003;112:896–9. 3. Rauh M, Koch A. Plasma N-terminal pro-B-type natriuretic peptide concentrations in a control population of infants and children. Clin Chem 2003;49: 1563–4. 4. Collinson PO, Barnes SC, Gaze DC, Galasko G, Lahiri A, Senior R. Analytical performance of the N terminal pro B type natriuretic peptide (NT-proBNP) assay on the Elecsys 1010 and 2010 analysers. Eur J Heart Fail 2004;6: 365–8. 5. Walther T, Stepan H, Pankow K, Gembardt F, Faber R, Schultheiss HP, et al. Relation of ANP and BNP to their N-terminal fragments in fetal circulation: evidence for enhanced neutral endopeptidase activity and resistance of BNP to neutral endopeptidase in the fetus. Br J Obstet Gynaecol 2004;111: 452–5. 6. Bakker J, Gies I, Slavenburg B, Bekers O, Delhaas T, van Dieijen-Visser M. Reference values for N-terminal pro-B-type natriuretic peptide in umbilical cord blood [Letter]. Clin Chem 2004;50:2465.